Swedish Orphan Biovitrum Acquires Dova Pharmaceuticals
Swedish Orphan Biovitrum acquired Dova Pharmaceuticals for $915.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Swedish Orphan Biovitrum
- Acquired Company
- Dova Pharmaceuticals
- Price
- $915.0M
- Acquisition Type
- Acquisition
- Announced
- September 30, 2019
Canonical: https://fsome.com/acquisitions/swedish-orphan-biovitrum-acquires-dova-pharmaceuticals-8196349 · For the full deal terms, timeline, and press references, please enable JavaScript.